Brazil seeks home-grown neonatal screening self-sufficiency by 2014
This article was originally published in Clinica
The Brazilian health ministry has approved R$8.4m (US$4.6m) in additional funding for the development over the next two years of a home-grown heel-prick neonatal screening test. The funding is to extend an R&D partnership already underway with the federal university of the state of Minas Gerais (UFMG).
You may also be interested in...
While the global health threat from the now officially named SARS-CoV-2 coronavirus has grown since the start of the quarterly earnings season in early February, even many of the companies reporting more recently do not appear overly concerned about potential business impact at this stage.
Sanofi seeks to delay decision clearing path for Mylan's Lantus biosimilar; says it should be able to get rehearing based on Federal Circuit's ruling that PTAB judges were not constitutionally appointed.
First Circuit reverses dismissal of direct purchasers' suit alleging improper listing of patent on device drive mechanism delayed competition; district court to decide if this constitutes antitrust violation.